BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh N, Ding L, Magee GA, Shavelle DM, Kashyap VS, Garg PK. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention. Circ Cardiovasc Interv 2020;13:e008791. [PMID: 32791948 DOI: 10.1161/CIRCINTERVENTIONS.119.008791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pärsson HN. High Platelet Reactivity Despite Taking Adenosine Diphosphate Receptor Inhibitors: Do We Need to Care? Eur J Vasc Endovasc Surg 2021:S1078-5884(21)00681-X. [PMID: 34627678 DOI: 10.1016/j.ejvs.2021.08.024] [Reference Citation Analysis]
2 Aday AW, Gutierrez JA. Antiplatelet Therapy Following Peripheral Arterial Interventions: The Choice Is Yours. Circ Cardiovasc Interv 2020;13:e009727. [PMID: 32791949 DOI: 10.1161/CIRCINTERVENTIONS.120.009727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Morrison A, Aday AW. Sex as a Key Determinant of Peripheral Artery Disease – Epidemiology, Differential Outcomes, and Proposed Biological Mechanisms. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tsai S, Li Y, Lee C, Cha S, Wang Y, Su T, Yu S, Yeh C. Mono or Dual Antiplatelet Therapy for Treating Patients with Peripheral Artery Disease after Lower Extremity Revascularization: A Systematic Review and Meta-Analysis. Pharmaceuticals 2022;15:596. [DOI: 10.3390/ph15050596] [Reference Citation Analysis]